© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to April
pro-mitotic selective MPS1 kinase inhibitor
dev. paused for 2nd candidate (BAY1217389)
from 2M cmpd biochem. HTS and SBDD
J. Med. Chem., Apr. 27, 2020
Bayer AG, Berlin, DE
BAY1161909 is one of two clinical candidates disclosed in a single paper from Bayer. The compounds have an interesting anti-cancer mechanism – rather than inhibiting cancer cell growth, they accelerate…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.